
Deborah Crouch
Examiner (ID: 4504, Phone: (571)272-0727 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1804, 1819, 2899, 1632, 3725 |
| Total Applications | 1439 |
| Issued Applications | 694 |
| Pending Applications | 237 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9823810
[patent_doc_number] => 08933295
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-13
[patent_title] => 'Identifying agents to treat alzheimer\'s disease-related decreased sorting behavior by administration to a triple transgenic mouse expressing mutant forms of APP, presenilin or tau'
[patent_app_type] => utility
[patent_app_number] => 12/993480
[patent_app_country] => US
[patent_app_date] => 2009-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8234
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12993480
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993480 | Identifying agents to treat alzheimer's disease-related decreased sorting behavior by administration to a triple transgenic mouse expressing mutant forms of APP, presenilin or tau | Jun 2, 2009 | Issued |
Array
(
[id] => 5367088
[patent_doc_number] => 20090304647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Production of Neural Stem Cells from Bone Marrow Tissue and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/476029
[patent_app_country] => US
[patent_app_date] => 2009-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14937
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304647.pdf
[firstpage_image] =>[orig_patent_app_number] => 12476029
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/476029 | Production of Neural Stem Cells from Bone Marrow Tissue and Use Thereof | May 31, 2009 | Abandoned |
Array
(
[id] => 6371815
[patent_doc_number] => 20100075417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'Methods and devices for isolating embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 12/454263
[patent_app_country] => US
[patent_app_date] => 2009-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6225
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20100075417.pdf
[firstpage_image] =>[orig_patent_app_number] => 12454263
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/454263 | Methods and devices for isolating embryonic stem cells | May 13, 2009 | Abandoned |
Array
(
[id] => 5367087
[patent_doc_number] => 20090304646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Multipotent/Pluripotent Cells and Methods'
[patent_app_type] => utility
[patent_app_number] => 12/465633
[patent_app_country] => US
[patent_app_date] => 2009-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 115777
[patent_no_of_claims] => 227
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304646.pdf
[firstpage_image] =>[orig_patent_app_number] => 12465633
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/465633 | Multipotent/Pluripotent Cells and Methods | May 12, 2009 | Abandoned |
Array
(
[id] => 6126711
[patent_doc_number] => 20110086424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'METHODS FOR PRODUCING ENUCLEATED ERYTHROID CELLS DERIVED FROM PLURIPOTENT STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/991111
[patent_app_country] => US
[patent_app_date] => 2009-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 50274
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086424.pdf
[firstpage_image] =>[orig_patent_app_number] => 12991111
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/991111 | METHODS FOR PRODUCING ENUCLEATED ERYTHROID CELLS DERIVED FROM PLURIPOTENT STEM CELLS | May 5, 2009 | Abandoned |
Array
(
[id] => 5496486
[patent_doc_number] => 20090264514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'SPHINGOMYELIN SYNTHASE 2 (SMS2) DEFICIENCY ATTENUATES NFkB ACTIVATION, A POTENTIAL ANTI-ATHEROGENIC PROPERTY'
[patent_app_type] => utility
[patent_app_number] => 12/426324
[patent_app_country] => US
[patent_app_date] => 2009-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8835
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264514.pdf
[firstpage_image] =>[orig_patent_app_number] => 12426324
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/426324 | SPHINGOMYELIN SYNTHASE 2 (SMS2) DEFICIENCY ATTENUATES NFkB ACTIVATION, A POTENTIAL ANTI-ATHEROGENIC PROPERTY | Apr 19, 2009 | Abandoned |
Array
(
[id] => 6619848
[patent_doc_number] => 20100293623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'Rabbit nuclear cloning method and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/386331
[patent_app_country] => US
[patent_app_date] => 2009-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10274
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20100293623.pdf
[firstpage_image] =>[orig_patent_app_number] => 12386331
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/386331 | Rabbit nuclear cloning method and uses thereof | Apr 14, 2009 | Abandoned |
Array
(
[id] => 8759875
[patent_doc_number] => 08420394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-16
[patent_title] => 'Culturing ectodermal cells under reduced oxygen tension'
[patent_app_type] => utility
[patent_app_number] => 12/410406
[patent_app_country] => US
[patent_app_date] => 2009-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8226
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12410406
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/410406 | Culturing ectodermal cells under reduced oxygen tension | Mar 23, 2009 | Issued |
Array
(
[id] => 6024840
[patent_doc_number] => 20110053166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'STEM CELL EXPRESSION CASSETTES'
[patent_app_type] => utility
[patent_app_number] => 12/920059
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 18723
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053166.pdf
[firstpage_image] =>[orig_patent_app_number] => 12920059
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/920059 | STEM CELL EXPRESSION CASSETTES | Feb 26, 2009 | Abandoned |
Array
(
[id] => 5992511
[patent_doc_number] => 20110014164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'EFFICIENT INDUCTION OF PLURIPOTENT STEM CELLS USING SMALL MOLECULE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/867615
[patent_app_country] => US
[patent_app_date] => 2009-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19589
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20110014164.pdf
[firstpage_image] =>[orig_patent_app_number] => 12867615
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/867615 | EFFICIENT INDUCTION OF PLURIPOTENT STEM CELLS USING SMALL MOLECULE COMPOUNDS | Feb 12, 2009 | Abandoned |
Array
(
[id] => 6204336
[patent_doc_number] => 20110067122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'Expression of Xenogenous (Human) Immunoglobulins in cloned, transgenic ungulates'
[patent_app_type] => utility
[patent_app_number] => 12/378061
[patent_app_country] => US
[patent_app_date] => 2009-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 31482
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20110067122.pdf
[firstpage_image] =>[orig_patent_app_number] => 12378061
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/378061 | Expression of Xenogenous (Human) Immunoglobulins in cloned, transgenic ungulates | Feb 8, 2009 | Abandoned |
Array
(
[id] => 4495355
[patent_doc_number] => 07947501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-24
[patent_title] => 'Gene recombination exchange system for stable gene modification in human ES cells'
[patent_app_type] => utility
[patent_app_number] => 12/322809
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 50
[patent_no_of_words] => 10250
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/947/07947501.pdf
[firstpage_image] =>[orig_patent_app_number] => 12322809
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/322809 | Gene recombination exchange system for stable gene modification in human ES cells | Feb 5, 2009 | Issued |
Array
(
[id] => 8375156
[patent_doc_number] => 08257947
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-04
[patent_title] => 'Extracellular matrix compositions produced under hypoxic culture conditions'
[patent_app_type] => utility
[patent_app_number] => 12/363488
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 18782
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12363488
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/363488 | Extracellular matrix compositions produced under hypoxic culture conditions | Jan 29, 2009 | Issued |
Array
(
[id] => 6460652
[patent_doc_number] => 20100190257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'Self-Assembly of a Cell-Microparticle Hybrid'
[patent_app_type] => utility
[patent_app_number] => 12/359336
[patent_app_country] => US
[patent_app_date] => 2009-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4638
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20100190257.pdf
[firstpage_image] =>[orig_patent_app_number] => 12359336
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/359336 | Self-Assembly of a Cell-Microparticle Hybrid | Jan 24, 2009 | Abandoned |
Array
(
[id] => 5514185
[patent_doc_number] => 20090214491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Method Of Using Mitotically Inactivated Stem Cells For Damaged Tissue Repair'
[patent_app_type] => utility
[patent_app_number] => 12/354522
[patent_app_country] => US
[patent_app_date] => 2009-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9020
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214491.pdf
[firstpage_image] =>[orig_patent_app_number] => 12354522
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/354522 | Cardiac tissue repair by mitotically inactivated pluripotent and/or embryonic stem cells | Jan 14, 2009 | Issued |
Array
(
[id] => 9350215
[patent_doc_number] => 08669106
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-11
[patent_title] => 'Erythrocytes differentiated in vitro from nanofiber expanded CD133+ cells'
[patent_app_type] => utility
[patent_app_number] => 12/351630
[patent_app_country] => US
[patent_app_date] => 2009-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 45
[patent_no_of_words] => 21597
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12351630
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/351630 | Erythrocytes differentiated in vitro from nanofiber expanded CD133+ cells | Jan 8, 2009 | Issued |
Array
(
[id] => 6071241
[patent_doc_number] => 20110046092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'SMALL MOLECULES FOR NEURONAL DIFFERENTIATION OF EMBRYONIC STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/747116
[patent_app_country] => US
[patent_app_date] => 2008-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 34011
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046092.pdf
[firstpage_image] =>[orig_patent_app_number] => 12747116
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747116 | Neurons, astrocytes and oligodendrocytes differentiated from a mammalian pluripotent or neural stem cells exposed to a pyridine deriviative | Dec 10, 2008 | Issued |
Array
(
[id] => 6371848
[patent_doc_number] => 20100075421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'Efficient method for nuclear reprogramming'
[patent_app_type] => utility
[patent_app_number] => 12/292717
[patent_app_country] => US
[patent_app_date] => 2008-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12908
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20100075421.pdf
[firstpage_image] =>[orig_patent_app_number] => 12292717
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/292717 | Efficient method for nuclear reprogramming | Nov 24, 2008 | Abandoned |
Array
(
[id] => 6401085
[patent_doc_number] => 20100305039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'Production of collagen in the milk of transgenic mammals'
[patent_app_type] => utility
[patent_app_number] => 12/268412
[patent_app_country] => US
[patent_app_date] => 2008-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13343
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20100305039.pdf
[firstpage_image] =>[orig_patent_app_number] => 12268412
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/268412 | Production of collagen in the milk of transgenic mammals | Nov 9, 2008 | Abandoned |
Array
(
[id] => 5434937
[patent_doc_number] => 20090169523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'HSC SELF-RENEWAL'
[patent_app_type] => utility
[patent_app_number] => 12/268320
[patent_app_country] => US
[patent_app_date] => 2008-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13869
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20090169523.pdf
[firstpage_image] =>[orig_patent_app_number] => 12268320
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/268320 | HSC SELF-RENEWAL | Nov 9, 2008 | Abandoned |